Clinical Trial Update: Preliminary Human Trials of F230 Tablets [Phase 1]

View source ↗

Summary

Phase 1 preliminary human trials of F230 tablets are underway, with recruitment ongoing for pulmonary hypertension. The sponsor is Beijing Continent Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• F230 tablets (F230)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Pulmonary Hypertension | Phase 1 | Status: RECRUITING